New ultrasound technique could catch liver cancer sooner in High-Risk patients
NCT ID NCT07590284
First seen May 15, 2026 · Last updated May 15, 2026
Summary
This study looks at whether a special ultrasound using a contrast agent called Sonazoid can find early-stage liver cancer better than a regular ultrasound. About 556 adults with liver cirrhosis will be monitored every 4 to 6 months with both methods. The goal is to see if Sonazoid ultrasound detects more cancers early, when treatment is most effective.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Tianjin Third Central Hospital
Tianjin, Tianjin Municipality, 300170, China
Conditions
Explore the condition pages connected to this study.